← Leaderboards
Yanlin Wang
Va Connecticut Healthcare System
$5,415,861
Attributed
$5,415,861
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $554.4K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,415,861 · 4
VA$0 · 1
By mechanism
R01$4,703,095 · 2
K08$655,420 · 1
F32$57,346 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularProductionChronic Kidney FailurePathologicInflammatoryGeneticPreventTreatment StrategyMyelogenousIn VitroKidneyFibrosisAmericanLeadInjuryFibroblastsBone MarrowChemokineExtracellular MatrixAffectCellsKidney DiseasesMacrophageImmune
Grant awards (28)
Novel mechanisms of kidney inflammation and fibrosis$471,240
R01 · FY2025 · DK · contact PI
Novel mechanisms of kidney inflammation and fibrosis$515,384
R01 · FY2024 · DK · contact PI
Targeting histone deacetylase 3 for chronic kidney disease$0
I01 · FY2024 · VA · contact PI
Novel mechanisms of kidney inflammation and fibrosis$554,406
R01 · FY2023 · DK · contact PI
Targeting histone deacetylase 3 for chronic kidney disease$0
I01 · FY2023 · VA · contact PI
Targeting histone deacetylase 3 for chronic kidney disease$0
I01 · FY2022 · VA · contact PI
Cellular and Molecular Mechanisms of Renal Fibrosis$369,000
R01 · FY2021 · DK · contact PI
Targeting histone deacetylase 3 for chronic kidney disease$0
I01 · FY2021 · VA · contact PI
Cellular and Molecular Mechanisms of Renal Fibrosis$369,000
R01 · FY2020 · DK · contact PI
Cellular and Molecular Mechanisms of Renal Fibrosis$377,414
R01 · FY2019 · DK · contact PI
Novel Mechanisms of Hypertensive Kidney Injury and Fibrosis$0
I01 · FY2019 · VA · contact PI
Cellular and Molecular Mechanisms of Renal Fibrosis$317,000
R01 · FY2018 · DK · contact PI
Cellular and Molecular Mechanisms of Renal Fibrosis$39,625
R01 · FY2018 · DK · contact PI
Novel Mechanisms of Hypertensive Kidney Injury and Fibrosis$0
I01 · FY2018 · VA · contact PI
Novel Mechanisms of Hypertensive Kidney Injury and Fibrosis$0
I01 · FY2017 · VA · contact PI
Cellular and Molecular Mechanisms of Renal Fibrosis$340,388
R01 · FY2016 · DK · contact PI
Novel Mechanisms of Hypertensive Kidney Injury and Fibrosis$0
I01 · FY2016 · VA · contact PI
Cellular and Molecular Mechanisms of Renal Fibrosis$340,388
R01 · FY2015 · DK · contact PI
Cellular and Molecular Mechanisms of Renal Fibrosis$340,388
R01 · FY2014 · DK · contact PI
Cellular and Molecular Mechanisms of Renal Fibrosis$328,474
R01 · FY2013 · DK · contact PI
Role of Bone Marrow-Derived Fibroblast Precursors in Cardiac Fibrosis$131,084
K08 · FY2013 · HL · contact PI
Cellular and Molecular Mechanisms of Renal Fibrosis$340,388
R01 · FY2012 · DK · contact PI
Role of Bone Marrow-Derived Fibroblast Precursors in Cardiac Fibrosis$131,084
K08 · FY2012 · HL · contact PI
Role of Bone Marrow-Derived Fibroblast Precursors in Cardiac Fibrosis$131,084
K08 · FY2011 · HL · contact PI
Role of Bone Marrow-Derived Fibroblast Precursors in Cardiac Fibrosis$131,084
K08 · FY2010 · HL · contact PI
Role of Bone Marrow-Derived Fibroblast Precursors in Cardiac Fibrosis$131,084
K08 · FY2009 · HL · contact PI
Novel Biomechanical Pathways in Cardiomyocyte Apoptosis$7,934
F32 · FY2002 · HL
Novel Biomechanical Pathways in Cardiomyocyte Apoptosis$49,412
F32 · FY2001 · HL